Application: Transfection (T)
Purpose: Lenti-vpak packaging system is designed to optimize the packing of most third generation lentivectors into virus particles which can express your lentiviral construct in a multitude of mammalian cells.
Specificity: - Generate high titers of viral particles
- Transfection reagent included
Characteristics: Lentiviral vectors as gene delivery tool are modified from HIV-1, with most of the viral genes removed. The lentiviral vector only contain the LTRs and the packaging signal, Psi. Lentiviral packaging genes are provided on separate plasmids, so the pseudo lentiviral particles are replication deficient.
Components: Packaging Plasmids - lyophilized 60 ug (5 x 60 ug)
TurboFectin Transfection Reagent - liquid 400 uL (5 x 400 uL)
Material not included: HEK 293T Cells, Opti-MEM, 0.45 micron filter

DNA dA-Tailing Kit

DNA Mod

In vitro DNA Amplification Kit

DNA Amp

Ligation-Free Cloning Kit

Clon

EasyScript Plus™ cDNA Synthesis Kit

cDNA

CRISPR Genomic Cleavage Detection Kit

GEEN

Mbead Virus Genomic Nucleic Acid Kit (MBeads Based)

DEx, REx Plasma, Serum

Ligation-Free Cloning Kit

Clon

Virus Nucleic Acid Isolation Kit

DEx, REx Plasma, Serum

Plasmid Miniprep Kit (QuickClean II)

DNA Purif

PCR Extraction Kit (QuickClean II)

DEx

Application Notes: Reagent Requirement by Vessel Type:
10 cm dish (2.5x10^6 cells) - 5 μg shRNA Plasmid, 6 μg Packaging Plasmid, 33 μL Transfection Reagent, 1.5 mL Opti-MEM per dish - 10 reactions per Kit

6-well plate (5x10^5 cells) - 1 μg shRNA Plasmid, 1.2 μg Packaging Plasmid, 6.6 μL Transfection Reagent, 250 μL Opti-MEM per vial - 50 reactions per Kit

12-well plate (2.5x10^5 cells) - 0.5 μg shRNA Plasmid, 0.6 μg Packaging Plasmid, 3.3 μL Transfection Reagent, 100 μL Opti-MEM per vial - 100 reactions per Kit
Comment: For Lenti shRNA application, we recommend a 6-well plate format.
Protocol: Lenti-vpak Packaging Kit Protocol
Protocol below is a for a 10cm dish, see table for different vessels and reagent requirements.
Day 1. Plate 2.5 x 10^6 of 293T cells on a 10cm dish in 10 mL complete growth media (antibiotic-free preferred) and incubate at 37 °C overnight.
Day 2. Transfection,
1) In a labeled ependorf tube, dilute the following DNA in 1.5mL Opti-MEM, and pipet gently to mix completely.
a. 5 μg of pLenti-shRNA construct or
5 μg of pLenti-ORF expression construct
b. 6 μg of packaging plasmids
2) Add 33µL of TurboFectin transfection reagent to the diluted DNA (not the reversed order), pipet gently to mix completely.
3) Incubate for 15 min at room temperature.
4) Add the transfection mixture prepared above dropwise to the cells. Gently rock the plate back-and-forth and from side-to-side to distribute the complex evenly. Incubate at 37°. Note: With TurboFectin, no medium change is necessary, directly add the transfection mixture to cells in complete growth media.
Day 3. Change the culture medium after 12-18 hours of incubation.
Day 4. Harvest the first batch of viral supernatant from the culture and store it at 4 °C. Add 10 mL fresh culture media to the cell culture.
Day 5. Harvest the second batch of viral supernatant then combine it with the first batch.
Filter through a 0.45μm filter to remove cellular debris.
The viral titer at this step is usually 10^6-10^7 TU/mL. The viral supernatant is now ready for the majority of transduction applications. If necessary, further concentration can be applied.

Note: Large ORF inserts might decrease the viral titer.
Reagent Preparation: Packaging Plasmids - Add 120 μL of distilled sterilized water (0.5 μg/μL). Please store at -20°C.
Restrictions: For Research Use only

Precaution of Use: Although the lentiviral transduction particles produced are replication incompetent, it is highly recommended that they be treated as Risk Group Level 2 (RGL-2) organisms. Follow all published RGL- 2 guidelines for handling and waste decontamination.
Storage: -20 °C
Storage Comment: store packaging plasmid and transfection reagent at -20°C

Liu, Ma, He, Wang, Jiang, Shao: "SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells." in: Autophagy, Vol. 11, Issue 12, pp. 2323-34, (2016) (PubMed).

Roberts, He, Erickson, Moreau et al.: "Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-α-lipoic acid, in human hepatocellular ..." in: Biochimica et biophysica acta, Vol. 1861, Issue 3, pp. 166-76, (2016) (PubMed).

Maio, Ghezzi, Verrigni, Rizza, Bertini, Martinelli, Zeviani, Singh, Carrozzo, Rouault: "Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB." in: Cell metabolism, Vol. 23, Issue 2, pp. 292-302, (2016) (PubMed).

Tan, Tedrow, Dutta, Juan-Guardela, Nouraie, Chu, Trejo Bittar, Ramani, Biswas, Veraldi, Kaminski, Zhang, Kass: "Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies." in: American journal of respiratory and critical care medicine, Vol. 194, Issue 11, pp. 1392-1402, (2016) (PubMed).

Reynolds, Hancock, Ray, Kener, Draney, Garland, Hardman, Bikman, Tessem: "β-Cell deletion of Nr4a1 and Nr4a3 nuclear receptors impedes mitochondrial respiration and insulin secretion." in: American journal of physiology. Endocrinology and metabolism, Vol. 311, Issue 1, pp. E186-201, (2016) (PubMed).

Kang, Kim, Lee, Kwon, Chun, Son, Kim, Lee, Youn, Youn: "TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation." in: Oncogene, (2016) (PubMed).

Wang, Xing, Liu, Guo, Li, Sun: "MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis." in: American journal of translational research, Vol. 8, Issue 7, pp. 3056-66, (2016) (PubMed).

Choudhary, Goetjen, Estus, Jacome-Galarza, Aguila, Lorenzo, Pilbeam: "Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts." in: The Journal of biological chemistry, Vol. 291, Issue 8, pp. 3882-94, (2016) (PubMed).

Ko, Rho, Jeon, Kim, Woo, Lee, Kim: "Bacteroides fragilis Enterotoxin Upregulates Heme Oxygenase-1 in Intestinal Epithelial Cells via a Mitogen-Activated Protein Kinase- and NF-κB-Dependent Pathway, Leading to Modulation of Apoptosis." in: Infection and immunity, Vol. 84, Issue 9, pp. 2541-54, (2016) (PubMed).

Pérez-Cañamás, Benvegnù, Rueda, Rábano, Satrústegui, Ledesma: "Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease." in: Molecular psychiatry, (2016) (PubMed).

Lin, Ouyang, Zhu, Huang, Liu, Chen, Cao, Li, Signer, Xu, Chung, Zhang, Lin, Patel, Wu, Cai, Hou, Wen, Jafari, Liu, Luo, Zhu, Qiu, Hou, Chen, Chen, Granet, Heichel, Shang, Li, Krawczyk et al.: "Lens regeneration using endogenous stem cells with gain of visual function. ..." in: Nature, Vol. 531, Issue 7594, pp. 323-8, (2016) (PubMed).

Song, Song, Jung, Choi, Baik, Jin, Kim, Chung: "Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)." in: The Journal of biological chemistry, Vol. 290, Issue 4, pp. 2321-33, (2015) (PubMed).

Miyo, Yamamoto, Konno, Colvin, Nishida, Koseki, Kawamoto, Ogawa, Hamabe, Uemura, Nishimura, Hata, Takemasa, Mizushima, Doki, Mori, Ishii: "Tumour-suppressive function of SIRT4 in human colorectal cancer." in: British journal of cancer, Vol. 113, Issue 3, pp. 492-9, (2015) (PubMed).

Kanthi, Hyman, Liao, Baek, Visovatti, Sutton, Goonewardena, Neral, Jo, Pinsky: "Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis." in: The Journal of clinical investigation, Vol. 125, Issue 8, pp. 3027-36, (2015) (PubMed).

Oh, Lee, Joung, Oh, Kim, Lee: "Insulin enhances RANKL-induced osteoclastogenesis via ERK1/2 activation and induction of NFATc1 and Atp6v0d2." in: Cellular signalling, Vol. 27, Issue 12, pp. 2325-31, (2015) (PubMed).

Lenti-vpak Packaging Kit

Product Details

Alternatives

Application Details

Handling

References

Recently viewed